Immunofluorescence localization of nuclear retinoid receptors in psoriasis versus normal human skin

Acta Dermato-Venereologica

Volumn 84, Issue 5, 2004, Pages 363-369

  Karlsson, Teresa ^a   Rollman, Ola ^a   Vahlquist, Anders ^a   Törmä, Hans ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Epidermis; Keratinocyte; Psoriasis; Retinoic acid; Retinoid receptor

Indexed keywords

DIMER; HETERODIMER; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOID X RECEPTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASAL CELL; CELL MATURATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG RECEPTOR BINDING; EPIDERMIS; EPIDERMIS CELL; FEMALE; GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; KERATINOCYTE; MALE; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSORIASIS; PUNCH BIOPSY; RARALPHA GENE; REGULATORY MECHANISM; RXRALPHA GENE; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; PSORIASIS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTORS;

EID: 4744337524     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410035506     Document Type: Article

References (34)

1. Giguère V. Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling. Endocrin Rev 1994; 15: 61-79.
2. Louafi F, Stewart CE, Perks CM, Thomas MG, Holly JM. Role of the IGF-II receptor in mediating acute, non-genomic effects of retinoids and IGF-II on keratinocyte cell death. Exp Dermatol 2003; 12: 426-434.
3. Fisher G, Talwar H, Xiao J-H, Datta S, Reddy A, Gaub M-P, et al. Immunological identification and functional quantitation of retinoic acid and retinoid X receptor proteins in human skin. J Biol Chem 1994; 269: 20629-20635.
4. Reichrath J, Mittmann M, Kamradt J, Muller SM. Expression of retinoid-X receptors (-α, -β, -γ) and retinoic acid receptors (-α, -β, -γ) in normal human skin: an immunohistological evaluation. Histochem J 1997; 29: 127-133.
5. Xu XC, Wong WY, Goldberg L, Baer SC, Wolf JE, Ramsdell WM, et al. Progressive decreases in nuclear retinoid receptors during skin squamous carcinogenesis. Cancer Res 2001; 61: 4306-4310.
6. Wang Z, Boudjelal M, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med 1999; 5: 418-422.
7. Darwiche N, Scita G, Jones C, Rutberg S, Greenwald E, Tennenbaum T, et al. Loss of retinoic acid receptors in mouse skin and skin tumors is associated with activation of the ras(Ha) oncogene and high risk for premalignant progression. Cancer Res 1996; 56: 4942-4949.
8. Kumar R, Shoemaker AR, Verma AK. Retinoic acid nuclear receptors and tumor promotion: decreased expression of retinoic acid nuclear receptors by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate. Carcinogenesis 1994; 15: 701-705.
9. Lotan RM. Squamous differentiation and retinoids. Cancer Treat Res 1995; 74: 43-72.
10. Darwiche N, Celli G, Tennenbaum T, Glick AB, Yuspa SH, DeLuca LM. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid x receptors. Cancer Res 1995; 55: 2774-2782.
11. Monzon RI, Fillmore C, Hudson LG. Functional consequences of reduced retinoic acid receptor gamma expression in a human squamous cell carcinoma line. Mol Pharmacol 1997; 51: 377-382.
12. Lufkin T, Lohnes D, Mark M, Dierich A, Gorry P, Gaub MP, et al. High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice. Proc Natl Acad Sci U S A 1993; 90: 7225-7229.
13. Lohnes D, Kastner P, Dierich A, Mark M, Lemeur M, Chambon P. Function of retinoic acid receptor γ in the mouse. Cell 1993; 73: 643-658.
14. Saitou M, Sugai S, Tanaka T, Shimouchi K, Fuchs E, Narumiya S, et al. Inhibition of skin development by targeted expression of a dominant-negative retinoic acid receptor. Nature 1995; 374: 159-162.
15. Attar PS, Wertz PW, McArthur M, Imakado S, Bickenbach JR, Roop DR. Inhibition of retinoid signaling in transgenic mice alters lipid processing and disrupts epidermal barrier function. Mol Endocrinol 1997; 11: 792-800.
16. Imakado S, Bickenbach JR, Bundman DS, Rothnagel JA, Attar PS, Wang XJ, et al. Targeting expression of a dominant-negative retinoic acid receptor mutant in the epidermis of transgenic mice results in loss of barrier function. Genes Dev 1995; 9: 317-329.
17. Ghadially R, Reed JT, Elias PM. Stratum corneum structure and function correlates with phenotype in psoriasis. J Invest Dermatol 1996; 107: 558-564.
18. Li M, Chiba H, Warot X, Messaddeq N, Gerard C, Chambon P, et al. RXR-alpha ablation in skin keratinocytes results in alopecia and epidermal alterations. Development 2001; 128: 675-688.
19. Törmä H, Karlsson T, Michaelsson G, Rollman O, Vahlquist A. Decreased mRNA levels of retinoic acid receptor α, retinoid X receptor α and thyroid hormone receptor α in lesional psoriatic skin. Acta Derm Venereol 2000; 80: 4-9.
20. Elder JT, Fisher GJ, Zhang Q-Y, Eisen D, Krust A, Kastner P, et al. Retinoic acid receptor gene expression in human skin. J Invest Dermatol 1991; 96: 425-433.
21. Reichrath J, Munssinger T, Kerber A, Rochette-Egly C, Chambon P, Bahmer FA, et al. In situ detection of retinoid-X receptor expression in normal and psoriatic human skin. Br J Dermatol 1995; 133: 168-175.
22. 3 receptor and retinoid X receptors in psoriatic skin: the receptor levels correlate with the receptor binding to DNA. Br J Dermatol 1998; 138: 225-228.
23. Thacher SM, Vasudevan J, Tsang KY, Nagpal S, Chandraratna RA. New dermatological agents for the treatment of psoriasis. J Med Chem 2001; 44: 281-297.
24. Floyd ZE, Stephens JM. Interferon-gamma-mediated activation and ubiquitin-proteasome-dependent degradation of PPARgamma in adipocytes. J Biol Chem 2002; 277: 4062-4068.
25. Boudjelal M, Wang Z, Voorhees JJ, Fisher GJ. Ubiquitin/proteasome pathway regulates levels of retinoic acid receptor gamma and retinoid X receptor alpha in human keratinocytes. Cancer Res 2000; 60: 2247-2252.
26. Westergaard M, Henningsen J, Johansen C, Rasmussen S, Lyhne Svendsen M, Birk Jensen U, et al. Expression and localization of peroxisome proliferator-activated receptors and nuclear factor κB in normal and lesional psoriatic skin. J Invest Dermatol 2003; 121: 1104-1117.
27. Nagpal S, Athanikar J, Chandraratna RA. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor α. J Biol Chem 1995; 270: 923-927.
28. Eckert RL, Crish JF, Banks EB, Welter JF. The epidermis: genes on - genes off. J Invest Dermatol 1997; 109: 501-509.
29. Karlsson T, Virtanen M, Sirsjö A, Rollman O, Vahlquist A, Törmä H. Topical retinoic acid alters the expression of cellular retinoic acid binding protein-I and cellular retinoic acid binding protein-II in non-lesional but not in lesional psoriatic skin. Exp Dermatol 2002; 11: 143-152.
30. Siegenthaler G, Tomatis I, Didierjean L, Jaconi S, Saurat J-H. Overexpression of cellular retinoic acid binding protein type II (CRABP-II) and down-regulation of CRABP-I in psoriatic skin. Dermatology 1992; 185: 251-256.
31. Di W, Li XY, Datta S, Åström A, Fisher GJ, Chambon P, et al. Keratinocyte-specific retinoid regulation of human cellular retinoic acid binding protein-II (hCRAB-PII) gene promoter requires an evolutionarily conserved DR1 retinoic acid-responsive element. J Invest Dermatol 1998; 111: 1109-1115.
32. Gaub M-P, Lutz Y, Ghyselinck NB, Scheuer I, Pfister V, Chambon P, et al. Nuclear detection of cellular retinoic acid binding proteins I and II with new antibodies. J Histochem Cytochem 1998; 46: 1103-1111.
33. Delva L, Bastie JN, Rochette-Egly C, Kraiba R, Balitrand N, Despouy G, et al. Physical and functional interactions between cellular retinoic acid binding protein II and the retinoic acid-dependent nuclear complex. Mol Cell Biol 1999; 19: 7158-7167.
34. Dong D, Ruuska SE, Levinthal DJ, Noy N. Distinct roles for cellular retinoic acid-binding proteins I and II in regulating signaling by retinoic acid. J Biol Chem 1999; 274: 23695-23698.